1 completed, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Hepatic Impairment: new trials by email Literature Review of Hepatic Impairment trials Research Report on Hepatic Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single and Repeat Dose Trial in Participants With Hepatic Impairment GB1211, Placebo - Hepatic Impairment | Phase 1 / Phase 2 | Unknown | Galecto Biotech AB | 54 | 2021-09-09 | 2023-05-11 |
| A Study of LCZ696 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers LCZ696 - Hepatic Impairment | Phase 2 | Completed | Novartis Pharmaceuticals | 32 | 2012-09-01 | 2015-08-10 |
Liver Cirrhosis (1)
Digestive System Diseases (1) · Fibrosis (1) · Liver Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
sacubitril and valsartan sodium hydrate drug combination (1)
Galecto Biotech AB (1) · Novartis Pharmaceuticals (1)
Bulgaria (1) · Germany (1)